• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Viant acquires Meraqi Medical

Viant acquires Meraqi Medical

September 11, 2019 By Sean Whooley

Viant announced today that it has acquired Meraqi Medical marking the medical device contract manufacturer’s fourth acquisition in two years.

Viant said the acquisition of Fremont, Calif.-based Meraqi will expand its range of interventional technologies, bioelectronics and minimally invasive surgical devices. It will also offer a West Coast design and development hub to compliment Viant’s East Coast D&D center and global network, the company said in a news release.

Foxborough, Mass.-based Viant said it plans to integrate Meraqi’s engineering and design capabilities to expand product offerings, optimize supply chains and improve quality while managing costs.

Viant partnered with Water Street Healthcare Partners and JLL Partners in 2016 to help it expand its design, development and manufacturing portfolio. In July of this year, the company announced the appointment of Alton Shader as CEO.

Viant said it believes the Meraqi acquisition will be its next step forward in the medtech space. Financial details of the acquisition were not disclosed.

“Meraqi stands out for its deep technical knowledge, passion for innovation and agility to help customers advance their technologies,” Declan Smyth, president of franchise at Viant, said in the release. “Adding Meraqi’s expertise to Viant’s breadth of capabilities and global scale provides our customers with expanded access to end-to-end solutions for all their medtech needs.”

“Joining Viant will give our customers access to a world-class, quality-focused organization with global manufacturing facilities and scale,” added Meraqi founder Al Hershey. “Additionally, this will enable Meraqi to accelerate the expansion of our capabilities and better serve our customers. Our shared passion for supporting innovative devices to address unmet patient needs and loving what we do makes this a very exciting time for our two companies and for our customers.”

In July 2018, Viant (then MedPlast, LLC) acquired Integer Holding Corporation’s Advanced Surgical and Orthopedics business. In 2017, the company acquired Coastal Life Technology and Vention Medical’s Device Manufacturing Services business.

Filed Under: Business/Financial News, Contract Manufacturing, Featured, Mergers & Acquisitions, News Well Tagged With: viant

More recent news

  • A new way to monitor glucose: Glucotrack explains 3-year CBGM implant technology
  • Dexcom continues advances in AI for CGM, type 2 diabetes awareness
  • Tandem continues to deliver more options, benefits for those with diabetes
  • Breaking: Sequel to launch twiist automated insulin delivery system next month
  • Dexcom shares U.S. report on CGM benefits for type 2 diabetes

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy